164 related articles for article (PubMed ID: 12466783)
1. Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation.
Keng FY; Chang SM; Cwajg E; He ZX; Lakkis NM; Nagueh SF; Spencer WH; Verani MS
J Nucl Cardiol; 2002; 9(6):594-600. PubMed ID: 12466783
[TBL] [Abstract][Full Text] [Related]
2. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
Nagueh SF; Lakkis NM; He ZX; Middleton KJ; Killip D; Zoghbi WA; Quiñones MA; Roberts R; Verani MS; Kleiman NS; Spencer WH
J Am Coll Cardiol; 1998 Jul; 32(1):225-9. PubMed ID: 9669274
[TBL] [Abstract][Full Text] [Related]
3. Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy.
Carasso S; Woo A; Yang H; Schwartz L; Vannan MA; Jamorski M; Linghorne M; Wigle ED; Rakowski H
J Am Soc Echocardiogr; 2008 May; 21(5):493-9. PubMed ID: 17961980
[TBL] [Abstract][Full Text] [Related]
4. Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion.
Kuhn H; Gietzen FH; Schäfers M; Freick M; Gockel B; Strunk-Müller C; Jachmann E; Schober O
Eur Heart J; 1999 Dec; 20(24):1808-17. PubMed ID: 10581139
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of left ventricular myocardial perfusion and function using gated SPECT in patients with hypertrophic obstruction cardiomyopathy following percutaneous transluminal septal myocardial ablation.
Zhang L; Liu R; Qiao SB; Sun XX; He ZX; Tian YQ
Nucl Med Commun; 2014 Jul; 35(7):762-6. PubMed ID: 24681766
[TBL] [Abstract][Full Text] [Related]
6. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
[TBL] [Abstract][Full Text] [Related]
7. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
8. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U
Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776
[TBL] [Abstract][Full Text] [Related]
9. Value of gated SPECT in the analysis of regional wall motion of the interventricular septum after coronary artery bypass grafting.
Giubbini R; Rossini P; Bertagna F; Bosio G; Paghera B; Pizzocaro C; Canclini S; Terzi A; Germano G
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1371-7. PubMed ID: 15221295
[TBL] [Abstract][Full Text] [Related]
10. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
[TBL] [Abstract][Full Text] [Related]
11. Myocardial perfusion after percutaneous transluminal septal myocardial ablation as assessed by myocardial contrast echocardiography in patients with hypertrophic obstructive cardiomyopathy.
Pedone C; Biagini E; Galema TW; Vletter WB; ten Cate FJ
J Am Soc Echocardiogr; 2006 Aug; 19(8):982-6. PubMed ID: 16880092
[TBL] [Abstract][Full Text] [Related]
12. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
Gietzen FH; Leuner CJ; Raute-Kreinsen U; Dellmann A; Hegselmann J; Strunk-Mueller C; Kuhn HJ
Eur Heart J; 1999 Sep; 20(18):1342-54. PubMed ID: 10462469
[TBL] [Abstract][Full Text] [Related]
13. Mid-systolic septal deceleration. A new sign of left ventricular outflow tract obstruction obtained by color-coded tissue Doppler echocardiography.
Breithardt OA; Stolle B; Franke A; Janssens U; Hanrath P; Kuhn H
Z Kardiol; 2003 Dec; 92(12):1003-7. PubMed ID: 14663610
[TBL] [Abstract][Full Text] [Related]
14. Technology insight: transcoronary ablation of septal hypertrophy.
Burri H; Sigwart U
Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):101-7. PubMed ID: 16265381
[TBL] [Abstract][Full Text] [Related]
15. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
[TBL] [Abstract][Full Text] [Related]
16. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
Qin JX; Shiota T; Lever HM; Kapadia SR; Sitges M; Rubin DN; Bauer F; Greenberg NL; Agler DA; Drinko JK; Martin M; Tuzcu EM; Smedira NG; Lytle B; Thomas JD
J Am Coll Cardiol; 2001 Dec; 38(7):1994-2000. PubMed ID: 11738306
[TBL] [Abstract][Full Text] [Related]
17. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
18. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre.
Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L
Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612
[TBL] [Abstract][Full Text] [Related]
19. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
[TBL] [Abstract][Full Text] [Related]
20. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients.
Aqel RA; Hage FG; Zohgbi GJ; Tabereaux PB; Lawson D; Heo J; Perry G; Epstein AE; Dell' Italia LJ; Iskandrian AE
Am J Cardiol; 2008 May; 101(9):1328-33. PubMed ID: 18435966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
